VM
Velleca Mark A.
Director
BoardM
Insider track record
Board DirectorNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Velleca Mark A., Director. Officer active across 2 companies, notably G1 Therapeutics, Inc.. Aggregated, 18 filings have been logged. History available since 11 May 2021. The latest transaction was filed on 30 January 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Velleca Mark A.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
75,000 shares0Common StockSEC:0001415889-25-002494:0
5,208 shares@ US$3.6018.7% of flowCommon StockSEC:0001415889-23-013339:0
57,286 shares@ US$0.3915.2% of flowCommon StockSEC:0001562180-23-006271:0
8,929 shares@ US$2.1018.2% of flowCommon StockSEC:0001415889-23-009959:0
11,228 shares@ US$1.6718.8% of flowCommon StockSEC:0001415889-23-005218:0
8,424 shares@ US$1.5012.6% of flowCommon StockSEC:0001415889-22-012797:0
15,000 shares@ US$0.394.4% of flowCommon StockSEC:0001562180-22-007293:0
20,000 shares@ US$0.395.8% of flowCommon StockSEC:0001562180-22-006791:0
4,294 shares@ US$2.6212.0% of flowCommon StockSEC:0001415889-22-009773:0
80,000 shares@ US$0.3922.9% of flowCommon StockSEC:0001562180-22-006214:0
5,542 shares@ US$2.030.0077% mcap57.5% of flowCommon StockSEC:0001415889-22-006741:0
2,897 shares@ US$3.020.0057% mcap42.5% of flowCommon StockSEC:0001415889-22-003185:0
15,000 shares@ US$0.397.4% of flowCommon StockSEC:0001562180-22-001223:0
40,000 shares@ US$0.3913.5% of flowCommon StockSEC:0001562180-21-006964:0
10,000 shares@ US$0.393.3% of flowCommon StockSEC:0001562180-21-004949:0
10,000 shares@ US$0.393.2% of flowCommon StockSEC:0001562180-21-004348:0
20,000 shares@ US$0.396.4% of flowCommon StockSEC:0001562180-21-003737:0
10,000 shares@ US$0.393.2% of flowCommon StockSEC:0001562180-21-003460:0
About Velleca Mark A.
Velleca Mark A. is Administrateur and has filed 18 forms in total. In the recent sample of 18 filings, the transactions are Levée d'options, with individual amounts including EUR 30,676.46442924923 at G1 Therapeutics, Inc. on 2022-08-18, EUR 20,386.65540189243 at G1 Therapeutics, Inc. on 2023-08-10, and EUR 17,717.21855300784 at Black Diamond Therapeutics, Inc. on 2023-03-20, over the period from 2021-05-13 to 2025-01-31.